Newest first
New topics page 4
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 4 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Racemisation and why it is invisible to a mass measurement
Posting this under the heading it deserves: Racemisation and why it is invisible to a mass measurement Everything below is what sits behind that. A question about racemisation that I think has a definite…
|
+120 | 127 | 41k | 1mo |
|
Heart failure with preserved ejection fraction: symptom endpoints
Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable. Heart failure with preserved ejection keeps being re-asked here and I…
|
+19 | 23 | 311 | 12d |
|
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction
The question in the title: Why a glucagon receptor agonist in a weight-loss compound is not a contradiction I will give what I have already checked below so nobody repeats it. I would like to disagree…
|
+43 | 47 | 19k | 2d |
|
Sulphur-smelling eructation: mechanism and what helps
Sulphur-smelling eructation: mechanism and what helps — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on sulphur-smelling…
|
2 | 58 | 1d | |
|
Why a pen's dose steps are fixed and what that costs you
The question in the title: Why a pen's dose steps are fixed and what that costs you I will give what I have already checked below so nobody repeats it. A question about a device rather than about a compound,…
|
4 | 2.5k | 23h | |
|
About the Receptor biology category
GLP-1, GIP, glucagon and amylin receptor signalling, bias, desensitisation and central versus peripheral action. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…
|
+6 | 10 | 34k | 20d |
|
What a simple presence test is genuinely useful for
What a simple presence test is genuinely useful for — that is the question, and I have not found it answered plainly anywhere I have looked. Trying to work out what would count as evidence on simple presence…
|
2 | 58 | 1d | |
|
Micronutrient adequacy at low total intake
Micronutrient adequacy at low total intake — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as evidence on micronutrient adequacy, before collecting…
|
+93 | 99 | 5.8k | 1mo |
|
Language barriers in accessing a prescription abroad
Language barriers in accessing a prescription abroad Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about language barriers in accessing in a thread last spring…
|
2 | 22k | 1h | |
|
Tracking a shortage from primary sources rather than rumour — the long version
On the subject in the title: Tracking a shortage from primary sources rather than rumour — the long version Working notes rather than a conclusion. Tracking a shortage keeps being re-asked here and I think…
|
2 | 60 | 1d | |
|
[2026 update] Travelling with an injectable: documentation and practicalities
Travelling with an injectable: documentation and practicalities Writing it up because I had to work it out twice and would rather nobody else did. Dated regional question, February 2026, because everything in…
|
+107 | 111 | 12k | 1d |
|
Sulfonylureas: the interaction most worth taking seriously — what changed since
On the subject in the title: Sulfonylureas: the interaction most worth taking seriously — what changed since Working notes rather than a conclusion. What changes if the standard account of Sulfonylureas is…
|
+3 | 7 | 35k | 1d |
|
Asking a follow-up: new topic or new reply?
Asking a follow-up: new topic or new reply? — that is the question, and I have not found it answered plainly anywhere I have looked. Collecting what is known about asking a follow-up in one place, because it…
|
+68 | 73 | 40k | 1d |
|
[2026 update] Interpreting a result that disagrees with the supplier's certificate
On the subject in the title: Interpreting a result that disagrees with the supplier's certificate Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+121 | 128 | 51k | 17h |
|
Submitting a sample: the process end to end
On the subject in the title: Submitting a sample: the process end to end Working notes rather than a conclusion. Submitting a sample keeps being re-asked here and I think that is because the answer is…
|
+99 | 114 | 29k | 21h |
|
A certificate whose chromatogram axes do not match its stated method — one year on
A certificate whose chromatogram axes do not match its stated method — one year on Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on certificate…
|
+103 | 111 | 8.1k | 2mo |
|
Coming back to: Payment method and the leverage it gives you, ranked
Payment method and the leverage it gives you, ranked — setting out what I have, and where I think it stops being reliable. A payments question, with the mechanics separated from the money. What I would like…
|
+21 | 26 | 43k | 2d |
|
Compounds this community declines to help with, and why — does this still hold?
Compounds this community declines to help with, and why — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Putting the numbers in the first post,…
|
+3 | 7 | 26k | 7h |
|
Pages past their review date, listed — does this still hold?
Asking directly, because I could not find a straight answer: Pages past their review date, listed — does this still hold? I have spent a fortnight trying to pin Pages past down and I want to set out where I…
|
+49 | 56 | 39k | 11d |
|
[2026 update] Second opinions: how to seek one without burning the first
On the subject in the title: Second opinions: how to seek one without burning the first Working notes rather than a conclusion. Two things I would like separated before anyone answers on Second opinions,…
|
2 | 5.9k | 1d | |
|
Insurance and replacement policies, compared
On the subject in the title: Insurance and replacement policies, compared Working notes rather than a conclusion. I have spent a fortnight trying to pin insurance and replacement policies down and I want to…
|
+115 | 122 | 17k | 17h |
|
Carryover and the ghost peak from last week's standard — what changed since
Carryover and the ghost peak from last week's standard — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of Carryover…
|
+98 | 114 | 37k | 22d |
|
SURPASS-2 and the comparator dose question that will not go away — what changed since
Posting this under the heading it deserves: SURPASS-2 and the comparator dose question that will not go away — what changed since Everything below is what sits behind that. What changes if the standard…
|
+2 | 6 | 5.5k | 7h |
|
Injecting into an area that has become firm: why not to
Injecting into an area that has become firm: why not to Writing it up because I had to work it out twice and would rather nobody else did. Asking about the failure mode rather than the procedure, because the…
|
+82 | 92 | 26k | 1mo |
|
A reconstituted vial's beyond-use date and the reasoning behind common figures
Posting this under the heading it deserves: A reconstituted vial's beyond-use date and the reasoning behind common figures Everything below is what sits behind that. I have read the maintained page on this…
|
+125 | 129 | 45k | 2mo |
|
Pooling trials with different estimands
On the subject in the title: Pooling trials with different estimands Working notes rather than a conclusion. Asking about pooling trials with different estimands on behalf of the question I keep seeing asked…
|
+120 | 132 | 2.3k | 1d |
|
A structured critique template this community uses — a second dataset
On the subject in the title: A structured critique template this community uses — a second dataset Working notes rather than a conclusion. Posting a small dataset on structured critique template. It is mine,…
|
+47 | 51 | 16k | 15h |
|
Follow-up: The most useful thing you learned here that was not the answer you came for
On the subject in the title: The most useful thing you learned here that was not the answer you came for Working notes rather than a conclusion. A digression I have been saving for the right category. It is…
|
+30 | 34 | 9.7k | 11h |
|
Revisiting: Taste changes and food aversion, reported and discussed
Revisiting: Taste changes and food aversion, reported and discussed Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers…
|
+20 | 25 | 4.3k | 1d |
|
[2026 update] Temperature indicator cards: worth asking for?
Temperature indicator cards: worth asking for? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about Temperature indicator cards on behalf of the question I…
|
+21 | 26 | 4.5k | 1d |